OEB5 Preparative Liquid Chromatography System, ≤0.1 µg/m³ Containment (CAT#: STEM-BC-3064-ZJF)

This preparative liquid chromatography system is intended for purification of highly potent pharmaceutical compounds. It is suitable for selected anticancer agents, hormones, cytotoxic substances, immunosuppressants, and genotoxic materials. These products may have therapeutic doses at the microgram level and present carcinogenic, teratogenic, reproductive, or other toxicological risks. The system is designed around OEB5 containment requirements. The stated occupational exposure limit is typically no more than 0.1 µg/m³ as an eight-hour time-weighted average. Engineering controls are used to limit operator and environmental exposure during chromatographic processing. The contained design can cover material charging, separation, fraction collection, sampling, and discharge according to the selected configuration. Personal protective measures can supplement the equipment-level containment strategy. Process modules and containment interfaces can be customized for the compound, solvent system, batch scale, and production workflow.

Model: OEB5 Preparative Liquid Chromatography System
Containment classification: OEB5
Stated occupational exposure limit: ≤0.1 µg/m³
Exposure basis: 8-hour time-weighted average
Target compounds: Anticancer drugs, hormones, cytotoxic compounds, immunosuppressants, and genotoxic substances
Process type: Preparative liquid chromatography
Control approach: Engineering containment combined with personal protection
Configuration: Customizable according to compound, solvent, scale, and workflow

OEB5 high-containment design
Suitable for highly potent compounds
Exposure target ≤0.1 µg/m³
Supports toxic and genotoxic materials
Engineering-controlled processing
Configurable contained workflow
Preparative purification capability
Customizable process interfaces

STEM-BC-0225-ZJF
STEM-BC-0226-ZJF
STEM-BC-0227-ZJF
STEM-BC-0228-ZJF
STEM-BC-0229-ZJF